We are live on !
Find out more
Glen Eagle Advisors Portfolio holdings
AUM
$793M
Turnover
9.43%
1-Year Est. Return
21.06%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+21.06%
3 Year Est. Return
+68.54%
5 Year Est. Return
+82.5%
10 Year Est. Return
–
AUM
$793M
AUM Growth
+$79M
(+11%)
Cap. Flow
+$15M
Cap. Flow % of AUM
Cap. Flow %
1.9%
Top 10 Holdings %
Top 10 Hldgs %
37.12%
Holding
1,103
New
85
Increased
343
Reduced
181
Closed
19
Avg Time Held
5.1
years
Top 10 Avg Time Held
5.1
years
Top 20 Avg Time Held
5.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$3.22M |
| 2 |
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
|
+$2.83M |
| 3 |
Innovator Defined Wealth Shield ETF
BALT
|
+$2.18M |
| 4 |
Salesforce
CRM
|
+$1.04M |
| 5 |
CME Group
CME
|
+$978K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$2.21M |
| 2 |
iShares Gold Trust
IAU
|
+$1.57M |
| 3 |
Microsoft
MSFT
|
+$883K |
| 4 |
Fortinet
FTNT
|
+$779K |
| 5 |
FT Vest Buffered Allocation Defensive ETF
BUFT
|
+$774K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.95% |
| 2 | Technology | 12.83% |
| 3 | Healthcare | 6.51% |
| 4 | Financials | 5.02% |
| 5 | Consumer Discretionary | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
Amkor Technology
AMKR
$9.7B
| $862 | ﹤0.01% |
+10
| New | +$713 |
2026 Q2
0 quarters
|
|
1002
Teradata
TDC
$3.18B
| $832 | ﹤0.01% |
+24
| New | +$730 |
2026 Q2
0 quarters
|
|
1003
Host Hotels & Resorts
HST
$17B
| $830 | ﹤0.01% |
+35
| New | +$781 |
2026 Q2
0 quarters
|
|
1004
CNX Resources
CNX
$5.29B
| $814 | ﹤0.01% |
24
| – | – |
2024 Q2
8 quarters
|
|
1005
Humana
HUM
$50.6B
| $794 | ﹤0.01% |
+2
| New | +$569 |
2026 Q2
0 quarters
|
|
1006
Alexandria Real Estate Equities
ARE
$7.46B
| $793 | ﹤0.01% |
+15
| New | +$718 |
2026 Q2
0 quarters
|
|
1007
Globus Medical
GMED
$11B
| $790 | ﹤0.01% |
10
| – | – |
2019 Q1
29 quarters
|
|
1008
LyondellBasell Industries
LYB
$21.1B
| $790 | ﹤0.01% |
+15
| New | +$1.04K |
2026 Q2
0 quarters
|
|
1009
Lumen Technologies, Inc. Common Stock
LUMN
$4.6B
| $768 | ﹤0.01% |
100
| – | – |
2022 Q1
17 quarters
|
|
1010
Organon & Co
OGN
$3.61B
| $740 | ﹤0.01% |
55
+39
| +244% | +$466 |
2021 Q2
20 quarters
|
|
1011
Parsons
PSN
$5.11B
| $733 | ﹤0.01% |
14
| – | – |
2024 Q2
8 quarters
|
|
1012
Option Care Health
OPCH
$4.69B
| $671 | ﹤0.01% |
32
| – | – |
2024 Q2
8 quarters
|
|
1013
iShares Global Clean Energy ETF
ICLN
$2.07B
| $662 | ﹤0.01% |
32
| – | – |
2023 Q4
10 quarters
|
|
1014
Brighthouse Financial
BHF
$2.67B
| $633 | ﹤0.01% |
10
| – | – |
2023 Q2
12 quarters
|
|
1015
iShares MSCI Israel ETF
EIS
$871M
| $621 | ﹤0.01% |
5
| – | – |
2024 Q3
7 quarters
|
|
1016
Rayonier
RYN
$5.57B
| $617 | ﹤0.01% |
29
| – | – |
2026 Q1
1 quarter
|
|
1017
Ollie's Bargain Outlet
OLLI
$5.5B
| $615 | ﹤0.01% |
8
| – | – |
2024 Q2
8 quarters
|
|
1018
iShares MSCI Singapore ETF
EWS
$1.13B
| $613 | ﹤0.01% |
21
+1
| +5% | +$29 |
2024 Q3
7 quarters
|
|
1019
DELISTED
Leggett & Platt
LEG
| $586 | ﹤0.01% |
50
| – | – |
2022 Q2
16 quarters
|
|
1020
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$803M
| $581 | ﹤0.01% |
+120
| New | +$625 |
2026 Q2
0 quarters
|
|
1021
HF Sinclair
DINO
$21.7B
| $565 | ﹤0.01% |
8
| – | – |
2022 Q4
14 quarters
|
|
1022
Hormel Foods
HRL
$11.8B
| $564 | ﹤0.01% |
23
+1
| +5% | +$22 |
2019 Q4
26 quarters
|
|
1023
Teladoc Health
TDOC
$1.15B
| $551 | ﹤0.01% |
65
+15
| +30% | +$100 |
2017 Q3
35 quarters
|
|
1024
Riverview Bancorp
RVSB
$121M
| $543 | ﹤0.01% |
100
| – | – |
2021 Q3
19 quarters
|
|
1025
Ubiquiti
UI
$36.1B
| $534 | ﹤0.01% |
+1
| New | +$754 |
2026 Q2
0 quarters
|
|
Similar funds
BBES
GUB
KAS
Glen Eagle Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Glen Eagle Advisors held 1,103 positions worth $793M, up 11% from $714M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Glen Eagle Advisors's Q2 2026 filing shows 85 new, 343 increased, 181 reduced and 19 closed positions. Its largest new stake was ProShares Trust UltraShort Lehman 20+ Year Treasury: 4,375 shares worth $153K. The largest sale was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.21M.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.
- Glen Eagle Advisors's largest Q2 2026 buy was ProShares Trust UltraShort Lehman 20+ Year Treasury: 4,375 shares worth $153K.
- Glen Eagle Advisors added most to State Street SPDR Portfolio Short Term Treasury ETF in Q2 2026, an estimated $3.22M increase.
- Glen Eagle Advisors's biggest Q2 2026 reduction was ProShares S&P 500 Dividend Aristocrats ETF, cutting an estimated $2.21M.
- Glen Eagle Advisors fully exited Honeywell in Q2 2026, selling an estimated $249K.
- Glen Eagle Advisors's ten largest holdings make up 37% of its $793M portfolio in Q2 2026.
- Glen Eagle Advisors opened 85 new positions and closed 19 in Q2 2026.
- Glen Eagle Advisors's portfolio value rose 11% quarter-over-quarter to $793M.
Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.